VYNE Therapeutics Inc. Common Stock (VYNE) is a publicly traded Healthcare sector company. As of July 21, 2026, VYNE trades at $0.82 with a market cap of $25.62M and a P/E ratio of -1.22. VYNE moved +7.31% today. Year to date, VYNE is +35.17%; over the trailing twelve months it is -36.58%. Its 52-week range spans $0.28 to $4.30. Rallies surfaces VYNE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VYNE Therapeutics Inc. Common Stock (VYNE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VYNE moved +7.31% today.
| Metric | Value |
|---|---|
| Price | $0.82 |
| Market Cap | $25.62M |
| P/E Ratio | -1.22 |
| EPS | $-0.62 |
| Dividend Yield | 0.38% |
| 52-Week High | $4.30 |
| 52-Week Low | $0.28 |
| Volume | 1.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $570.00K |
| Net Income | $-26.48M |
| Gross Margin | 0.00% |
VYNE analyst coverage data. Average price target: $0.00.